Supply Shortage of Pfizer’s Covid Pill Causes Uneven Rollout in U.S.

Reopening America

Feb 8 2022 • 7 mins

The rollout of the Pfizer’s Covid pills has faced shortages and criticism that state health departments are not prioritizing those at the highest risk of serious illness. The Biden administration has purchased 20 million courses of the treatment but has only been able to release 265,000 courses due to production delays. Benjamin Ryan, contributor to NBC News, joins us for a look inside the U.S. rollout.

Learn more about your ad-choices at

See for privacy information.